1. Home
  2. AMBA vs TLX Comparison

AMBA vs TLX Comparison

Compare AMBA & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambarella Inc.

AMBA

Ambarella Inc.

HOLD

Current Price

$70.78

Market Cap

3.6B

Sector

Technology

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$11.69

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBA
TLX
Founded
2004
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.9B
IPO Year
2011
2024

Fundamental Metrics

Financial Performance
Metric
AMBA
TLX
Price
$70.78
$11.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
4
Target Price
$97.25
$21.13
AVG Volume (30 Days)
1.7M
108.6K
Earning Date
05-28-2026
08-19-2026
Dividend Yield
N/A
N/A
EPS Growth
37.32
N/A
EPS
N/A
N/A
Revenue
$295,402,000.00
N/A
Revenue This Year
$15.03
N/A
Revenue Next Year
$12.41
N/A
P/E Ratio
N/A
$150.33
Revenue Growth
N/A
N/A
52 Week Low
$48.30
$6.28
52 Week High
$96.69
$12.50

Technical Indicators

Market Signals
Indicator
AMBA
TLX
Relative Strength Index (RSI) 42.28 54.79
Support Level $69.37 $10.12
Resistance Level $71.02 $12.23
Average True Range (ATR) 3.38 0.22
MACD -1.56 0.00
Stochastic Oscillator 6.17 61.76

Price Performance

Historical Comparison
AMBA
TLX

About AMBA Ambarella Inc.

Ambarella Inc is a developer of low-power system-on-a-chip, or SoC, semiconductors and software for edge and physical artificial intelligence (AI) applications and intelligent automation. Its products are used in a wide variety of human viewing, computer vision for edge and physical AI applications, including a variety of video security cameras, automotive camera systems, fixed robots, autonomous mobile robots (AMRs), industrial applications, intelligent transportation systems, and consumer devices, such as action, drone and 360 degree cameras. The company operates as a single operating and reportable segment and derives substantially all of its revenue from development and sales of low-power AI-based processing and video and image processing SoC solutions.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: